Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.
Authors: Abe M; Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan., Yamaguchi T; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Fujita Y; Division of Pharmacy, Gunma Prefectural Cancer Center, Ōta, Gunma, Japan., Nishimura T; Department of Pharmacy, Wakayama Medical University Hospital, Wakayama, Wakayama, Japan., Kitagawa K; Division of Medical Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Hyōgo, Japan., Inui N; Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan., Hirano K; Department of Respiratory Medicine, Hyōgo Prefectural Amagasaki General Medical Center, Amagasaki, Hyōgo, Japan., Sakata Y; Department of Pharmacy, Hakodate Municipal Hospital, Hakodate, Hokkaido, Japan., Iihara H; Department of Pharmacy, Gifu University Hospital, Gifu, Gifu, Japan., Shibuya Y; Department of Transplant Surgery, Kōchi Health Science Center, Kōchi, Kōchi, Japan., Suzuki K; Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachiōji, Tokyo, Japan., Shibata K; Department of Medical Oncology, Kouseiren Takaoka Hospital, Takaoka, Toyama, Japan., Hori K; Department of Obstetrics and Gynecology, Kansai Rousai Hospital, Amagasaki, Hyōgo, Japan., Daga H; Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan., Nakayama T; Department of Pharmacy, Saitama Cancer Center, Kitaadachi-gun, Saitama, Japan., Sakata Y; Department of Pharmacy, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, Hiroshima, Japan., Takahashi TY; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Zenda S; Japan Supportive, Palliative and Psychosocial Oncology Group, Tokyo, Japan., Hashimoto H; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
Source: JAMA network open [JAMA Netw Open] 2023 May 01; Vol. 6 (5), pp. e2310894. Date of Electronic Publication: 2023 May 01.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37129897
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abe+M%22">Abe M</searchLink>; Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamaguchi+T%22">Yamaguchi T</searchLink>; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+Y%22">Fujita Y</searchLink>; Division of Pharmacy, Gunma Prefectural Cancer Center, Ōta, Gunma, Japan.<br /><searchLink fieldCode="AU" term="%22Nishimura+T%22">Nishimura T</searchLink>; Department of Pharmacy, Wakayama Medical University Hospital, Wakayama, Wakayama, Japan.<br /><searchLink fieldCode="AU" term="%22Kitagawa+K%22">Kitagawa K</searchLink>; Division of Medical Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Hyōgo, Japan.<br /><searchLink fieldCode="AU" term="%22Inui+N%22">Inui N</searchLink>; Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Hirano+K%22">Hirano K</searchLink>; Department of Respiratory Medicine, Hyōgo Prefectural Amagasaki General Medical Center, Amagasaki, Hyōgo, Japan.<br /><searchLink fieldCode="AU" term="%22Sakata+Y%22">Sakata Y</searchLink>; Department of Pharmacy, Hakodate Municipal Hospital, Hakodate, Hokkaido, Japan.<br /><searchLink fieldCode="AU" term="%22Iihara+H%22">Iihara H</searchLink>; Department of Pharmacy, Gifu University Hospital, Gifu, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Shibuya+Y%22">Shibuya Y</searchLink>; Department of Transplant Surgery, Kōchi Health Science Center, Kōchi, Kōchi, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+K%22">Suzuki K</searchLink>; Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachiōji, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shibata+K%22">Shibata K</searchLink>; Department of Medical Oncology, Kouseiren Takaoka Hospital, Takaoka, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Hori+K%22">Hori K</searchLink>; Department of Obstetrics and Gynecology, Kansai Rousai Hospital, Amagasaki, Hyōgo, Japan.<br /><searchLink fieldCode="AU" term="%22Daga+H%22">Daga H</searchLink>; Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nakayama+T%22">Nakayama T</searchLink>; Department of Pharmacy, Saitama Cancer Center, Kitaadachi-gun, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Sakata+Y%22">Sakata Y</searchLink>; Department of Pharmacy, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+TY%22">Takahashi TY</searchLink>; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Zenda+S%22">Zenda S</searchLink>; Japan Supportive, Palliative and Psychosocial Oncology Group, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hashimoto+H%22">Hashimoto H</searchLink>; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101729235%22">JAMA network open</searchLink> [JAMA Netw Open] 2023 May 01; Vol. 6 (5), pp. e2310894. <i>Date of Electronic Publication: </i>2023 May 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101729235 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2574-3805 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225743805%22">25743805 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Netw Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37129897
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamanetworkopen.2023.10894
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2310894
    Titles:
      – TitleFull: Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abe M
      – PersonEntity:
          Name:
            NameFull: Yamaguchi T
      – PersonEntity:
          Name:
            NameFull: Fujita Y
      – PersonEntity:
          Name:
            NameFull: Nishimura T
      – PersonEntity:
          Name:
            NameFull: Kitagawa K
      – PersonEntity:
          Name:
            NameFull: Inui N
      – PersonEntity:
          Name:
            NameFull: Hirano K
      – PersonEntity:
          Name:
            NameFull: Sakata Y
      – PersonEntity:
          Name:
            NameFull: Iihara H
      – PersonEntity:
          Name:
            NameFull: Shibuya Y
      – PersonEntity:
          Name:
            NameFull: Suzuki K
      – PersonEntity:
          Name:
            NameFull: Shibata K
      – PersonEntity:
          Name:
            NameFull: Hori K
      – PersonEntity:
          Name:
            NameFull: Daga H
      – PersonEntity:
          Name:
            NameFull: Nakayama T
      – PersonEntity:
          Name:
            NameFull: Sakata Y
      – PersonEntity:
          Name:
            NameFull: Takahashi TY
      – PersonEntity:
          Name:
            NameFull: Zenda S
      – PersonEntity:
          Name:
            NameFull: Hashimoto H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2023 May 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2574-3805
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: JAMA network open
              Type: main
ResultId 1